124 related articles for article (PubMed ID: 27215716)
1. Duodenal Neuroendocrine Tumors: Location Matters!
Sheikh MR; Osman H; Cheek S; Hunter S; Jeyarajah DR
Am Surg; 2016 May; 82(5):386-9. PubMed ID: 27215716
[TBL] [Abstract][Full Text] [Related]
2. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature.
Iwasaki T; Nara S; Kishi Y; Esaki M; Shimada K; Hiraoka N
Langenbecks Arch Surg; 2017 Sep; 402(6):925-933. PubMed ID: 27915372
[TBL] [Abstract][Full Text] [Related]
3. Pathologic grade and tumor size are associated with recurrence-free survival in patients with duodenal neuroendocrine tumors.
Untch BR; Bonner KP; Roggin KK; Reidy-Lagunes D; Klimstra DS; Schattner MA; Fong Y; Allen PJ; D'Angelica MI; DeMatteo RP; Jarnagin WR; Kingham TP; Tang LH
J Gastrointest Surg; 2014 Mar; 18(3):457-62; discussion 462-3. PubMed ID: 24448999
[TBL] [Abstract][Full Text] [Related]
4. Small pancreatic and periampullary neuroendocrine tumors: resect or enucleate?
Pitt SC; Pitt HA; Baker MS; Christians K; Touzios JG; Kiely JM; Weber SM; Wilson SD; Howard TJ; Talamonti MS; Rikkers LF
J Gastrointest Surg; 2009 Sep; 13(9):1692-8. PubMed ID: 19548038
[TBL] [Abstract][Full Text] [Related]
5. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
[TBL] [Abstract][Full Text] [Related]
6. Surgical management of superficial non-ampullary duodenal tumors.
Abe N; Suzuki Y; Masaki T; Mori T; Sugiyama M
Dig Endosc; 2014 Apr; 26 Suppl 2():57-63. PubMed ID: 24750150
[TBL] [Abstract][Full Text] [Related]
7. Duodenal neuroendocrine tumors: Somewhere between the pancreas and small bowel?
Gamboa AC; Liu Y; Lee RM; Zaidi MY; Staley CA; Kooby DA; Winer JH; Shah MM; Russell MC; Cardona K; Maithel SK
J Surg Oncol; 2019 Dec; 120(8):1293-1301. PubMed ID: 31621090
[TBL] [Abstract][Full Text] [Related]
8. A Multi-institutional Analysis of Duodenal Neuroendocrine Tumors: Tumor Biology Rather than Extent of Resection Dictates Prognosis.
Margonis GA; Samaha M; Kim Y; Postlewait LM; Kunz P; Maithel S; Tran T; Berger N; Gamblin TC; Mullen MG; Bauer TW; Pawlik TM
J Gastrointest Surg; 2016 Jun; 20(6):1098-105. PubMed ID: 27008594
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic treatment of sporadic small duodenal and ampullary neuroendocrine tumors.
Gincul R; Ponchon T; Napoleon B; Scoazec JY; Guillaud O; Saurin JC; Ciocirlan M; Lepilliez V; Pioche M; Lefort C; Adham M; Pialat J; Chayvialle JA; Walter T
Endoscopy; 2016 Nov; 48(11):979-986. PubMed ID: 27494453
[No Abstract] [Full Text] [Related]
10. The Risk Factors for Metastasis in Non-Ampullary Duodenal Neuroendocrine Tumors Measuring 20 mm or Less in Diameter.
Hatta W; Koike T; Iijima K; Asanuma K; Asano N; Musha H; Inomata Y; Sano T; Endo H; Ikehata A; Horii T; Ohyauchi M; Yokosawa S; Kasajima A; Fujishima F; Sasano H; Nakaya N; Nakamura T; Shimosegawa T
Digestion; 2017; 95(3):201-209. PubMed ID: 28315861
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome of endoscopic and surgical resection for foregut neuroendocrine tumors.
Jung HJ; Hong SJ; Han JP; Kim HS; Jeong GA; Cho GS; Kim HK; Ko BM; Lee MS
J Dig Dis; 2015 Oct; 16(10):595-600. PubMed ID: 26315879
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Endoscopic Mucosal Resection for Management of Small Duodenal Neuroendocrine Tumors.
Shroff SR; Kushnir VM; Wani SB; Gupta N; Jonnalagadda SS; Murad F; Early DS; Mullady DK; Edmundowicz SA; Azar RR
Surg Laparosc Endosc Percutan Tech; 2015 Oct; 25(5):e134-9. PubMed ID: 26271024
[TBL] [Abstract][Full Text] [Related]
13. Local resection for duodenal gastrointestinal stromal tumors.
Crown A; Biehl TR; Rocha FG
Am J Surg; 2016 May; 211(5):867-70. PubMed ID: 27033254
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes in patients with duodenal adenocarcinoma.
Lee SY; Lee JH; Hwang DW; Kim SC; Park KM; Lee YJ
ANZ J Surg; 2014 Dec; 84(12):970-5. PubMed ID: 23656271
[TBL] [Abstract][Full Text] [Related]
15. Method and timing of resection of superficial non-ampullary duodenal epithelial tumors.
Kakushima N; Ono H; Takao T; Kanemoto H; Sasaki K
Dig Endosc; 2014 Apr; 26 Suppl 2():35-40. PubMed ID: 24750146
[TBL] [Abstract][Full Text] [Related]
16. Is there an Optimal Surgical Approach to Neuroendocrine Tumors of the Ampulla? A Single Institution Experience Over 15 Years.
Baptiste GG; Postlewait LM; Ethun CG; Le N; Russell MC; Kooby DA; Staley CA; Maithel SK; Cardona K
Am Surg; 2016 Jul; 82(7):637-43. PubMed ID: 27457864
[TBL] [Abstract][Full Text] [Related]
17. Elevated Plasma Pancreastatin, but Not Chromogranin A, Predicts Survival in Neuroendocrine Tumors of the Duodenum.
Woltering EA; Beyer DT; Thiagarajan R; Ramirez RA; Wang YZ; Ricks MJ; Boudreaux JP
J Am Coll Surg; 2016 Apr; 222(4):534-42. PubMed ID: 26827125
[TBL] [Abstract][Full Text] [Related]
18. Surgery and prognosis of duodenal gastrinoma as a duodenal neuroendocrine tumor.
Norton JA
Best Pract Res Clin Gastroenterol; 2005 Oct; 19(5):699-704. PubMed ID: 16253894
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of Surgical and Endoscopic Resection of Duodenal Neuroendocrine Tumours (NETs): a Systematic Review of the Literature.
Dasari BVM; Al-Shakhshir S; Pawlik TM; Shah T; Marudanayagam R; Sutcliffe RP; Mirza DF; Muiesan P; Roberts KJ; Isaac J
J Gastrointest Surg; 2018 Sep; 22(9):1652-1658. PubMed ID: 29869091
[TBL] [Abstract][Full Text] [Related]
20. Endoscopic submucosal resection with a ligation device for the treatment of duodenal neuroendocrine tumors.
Osera S; Oono Y; Ikematsu H; Yano T; Kaneko K
Surg Endosc; 2016 Sep; 30(9):3928-32. PubMed ID: 26675937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
